Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Tytuł pozycji:

Does Cannabis Dependence Add on to the Neurocognitive Impairment Among Patients With Opioid Dependence? A Cross-Sectional Comparative Study.

Tytuł :
Does Cannabis Dependence Add on to the Neurocognitive Impairment Among Patients With Opioid Dependence? A Cross-Sectional Comparative Study.
Autorzy :
Ghosh A; Department of Psychiatry, Drug De-addiction and Treatment Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Basu D; Department of Psychiatry, Drug De-addiction and Treatment Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Mattoo SK; Department of Psychiatry, Drug De-addiction and Treatment Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Kumar Rana D; Department of Psychiatry, Drug De-addiction and Treatment Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Roub F; Department of Psychiatry, Drug De-addiction and Treatment Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Pokaż więcej
Źródło :
The American journal on addictions [Am J Addict] 2020 Mar; Vol. 29 (2), pp. 120-128. Date of Electronic Publication: 2020 Jan 17.
Typ publikacji :
Comparative Study; Journal Article
Język :
English
Imprint Name(s) :
Publication: Oxford : Wiley-Blackwell
Original Publication: Washington, DC : American Psychiatric Press, c1992-
MeSH Terms :
Marijuana Abuse/*psychology
Neurocognitive Disorders/*etiology
Opioid-Related Disorders/*psychology
Adolescent ; Adult ; Case-Control Studies ; Chronic Disease ; Cross-Sectional Studies ; Female ; Humans ; Linear Models ; Male ; Marijuana Abuse/complications ; Middle Aged ; Neurocognitive Disorders/diagnosis ; Neuropsychological Tests ; Opioid-Related Disorders/complications ; Young Adult
References :
Baldacchino A, Balfour DJ, Passetti F, et al. Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis. Neurosci Biobehav Rev. 2012;36:2056-2068. https://doi.org/10.1016/j.neubiorev.2012.06.006.
Baldacchino A, Armanyous M, Balfour DJ, et al. Neuropsychological functioning and chronic methadone use: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2017;73:23-38. https://doi.org/10.1016/j.neubiorev.2016.11.008.
Wollman SC, Hauson AO, Hall MG, et al. Neuropsychological functioning in opioid use disorder: a research synthesis and meta-analysis. Am J Drug Alcohol. 2019;45:11-25. https://doi.org/10.1080/00952990.2018.1517262.
Budney AJ, Bickel WK, Amass L. Marijuana use and treatment outcome among opioid-dependent patients. Addiction. 1998;93:493-503.
DuPont RL, Saylor KE. Marijuana and benzodiazepines in patients receiving methadone treatment. JAMA. 1989;261:3409. https://doi.org/10.1001/jama.1989.03420230061018.
Balhara YP, Jain R. Cannabis use among opioid-dependent individuals on opioid substitution therapy. J Pharmacol Pharmacother. 2014;5:203. https://doi.org/10.4103/0976-500X.136106.
Reisfield GM, Wasan AD, Jamison RN. The prevalence and significance of cannabis use in patients prescribed chronic opioid therapy: a review of the extant literature. Pain Med. 2009;10:1434-1441. https://doi.org/10.1111/j.1526-4637.2009.00726.x.
Schmidt LA, Jacobs LM, Spetz J. Young people's more permissive views about marijuana: local impact of state laws or national trend? Am J Public Health. 2016;106:1498-1503. https://doi.org/10.2105/AJPH.2016.303153.
Carliner H, Brown QL, Sarvet AL, et al. Cannabis use, attitudes, and legal status in the US: a review. Prev Med. 2017;104:13-23. https://doi.org/10.1016/j.ypmed.2017.07.008.
Blevins CE, Marsh E, Banes KE, et al. The implications of cannabis policy changes in washington on adolescent perception of risk, norms, attitudes, and substance use. Subst Abuse. 2018;12:1178221818815491. https://doi.org/10.1177/1178221818815491.
Wiese B, Wilson-Poe AR. Emerging evidence for cannabis' role in opioid use disorder. Cannabis Cannabinoid Res. 2018;3:179-189. https://doi.org/10.1089/can.2018.0022.
Hill KP, Palastro MD, Johnson B, et al. Cannabis and pain: a clinical review. Cannabis Cannabinoid Res. 2017;2:96-104. https://doi.org/10.1089/can.2017.0017.
Crean RD, Crane NA, Mason BJ. An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med. 2011;5:1-8. https://doi.org/10.1097/ADM.0b013e31820c23fa.
Scott JC, Slomiak ST, Jones JD, et al. Association of cannabis with cognitive functioning in adolescents and young adults: a systematic review and meta-analysis. JAMA Psychiatry. 2018;75:585-595. https://doi.org/10.1001/jamapsychiatry.2018.0335.
Ersche KD, Sahakian BJ. The neuropsychology of amphetamine and opiate dependence: implications for treatment. Neuropsychol Rev. 2007;17:317-336. https://doi.org/10.1007/s11065-007-9033-y.
Fals-Stewart W. Ability to counselors to detect cognitive impairment amongsubstance-abusing patients: an examination of diagnostic efficiency. Exp Clin Psychopharmacol. 1997;5:39-50.
Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22-33.
Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs. 2003;35:253-259. https://doi.org/10.1080/02791072.2003.10400007.
Sutherland G, Edwards G, Taylor C, et al. The measurement of opiate dependence. Br J Addict. 1986;81:485-494. https://doi.org/10.1111/j.1360-0443.1986.tb00360.x.
Bechara A. The role of emotion in decision-making: evidence from neurological patients with orbitofrontal damage. Brain Cognition. 2004;55:30-40. https://doi.org/10.1016/j.bandc.2003.04.001.
Greve KW. The WCST-64: a standardized short-form of the Heartoin Card Sorting Test. ClinNeuropsychol. 2001;15:228-234. https://doi.org/10.1076/clin.15.2.228.1901.
Heaton RK. Wisconsin Card Sorting Test Manual. Odessa, FL: Psychological Assessment Resources; 1981.
Meule A. Reporting and interpreting working memory performance in n-back tasks. Front Psychol. 2017;8:352. https://doi.org/10.3389/fpsyg.2017.00352.
Salthouse TA. What cognitive abilities are involved in trail-making performance? Intelligence. 2011;39:222-232. https://doi.org/10.1016/j.intell.2011.03.001.
Raven J. Raven progressive matrices. In: McCallum RS, ed. Handbook of nonverbal assessment. Boston, MA: Springer; 2003:223-237.
SPSS Inc. Released. SPSS for Windows, Version 14.0. Chicago: SPSS Inc.; 2006.
Jackson NJ, Isen JD, Khoddam R, et al. Impact of adolescent marijuana use on intelligence: results from two longitudinal twin studies. Proc Natl Acad Sci USA. 2016;113:E500-E508. https://doi.org/10.1073/pnas.1516648113.
Colom R, Karama S, Jung RE, et al. Human intelligence and brain networks. Dialogues Clin Neurosci. 2010;12:489-501.
Tervo-Clemmens B, Simmonds D, Calabro FJ, et al. Early cannabis use and neurocognitive risk: a prospective functional neuroimaging study. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3:713-725. https://doi.org/10.1016/j.bpsc.2018.05.004.
Volkow ND, Wang GJ, Tomasi D, et al. Unbalanced neuronal circuits in addiction. Curr Opin Neurobiol. 2013;23:639-648. https://doi.org/10.1016/j.conb.2013.01.002.
Kamp F, Proebstl L, Penzel N, et al. Effects of sedative drug use on the dopamine system: a systematic review and meta-analysis of in vivo neuroimaging studies. Neuropsychopharmacology. 2019;44:660-667. https://doi.org/10.1038/s41386-018-0191-9.
Volkow ND, Chang L, Wang GJ, et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry. 2001;158:2015-2021. https://doi.org/10.1176/appi.ajp.158.12.2015.
Entry Date(s) :
Date Created: 20200118 Date Completed: 20200930 Latest Revision: 20200930
Update Code :
20201023
DOI :
10.1111/ajad.12986
PMID :
31951069
Czasopismo naukowe
Background and Objectives: Chronic opioid exposure has been linked with neurocognitive impairments. Evidence of residual impairment with cannabis use is less consistent. We investigated whether patients with opioid and cannabis dependence perform poorly compared with those with opioid dependence alone.
Methods: We recruited three groups of participants aged 18 to 55 years: opioid and cannabis dependence (OCaD; n = 21), only opioid dependence (OD; n = 19), and a control group (HC; n = 20). Subjects with other substance use, human immunodeficiency virus, head injury, epilepsy, and severe mental illness were excluded. Cognitive tests, performed after at least 1 week of abstinence, consisted of the Wisconsin card sorting test (WCST), Iowa gambling task (IGT), trail making tests A and B (TMT-A and B), verbal and visual N-back test (NBT), and standard progressive matrices for intelligence quotient (IQ). The general linear model was used to compare the groups with age and years of education as covariates.
Results: IQ and severity of opioid dependence were comparable in the three groups. The mean duration of cannabis use was 76.2 (±39.4) months. Compared with the HC, both OD and OCaD had significant impairment on the IGT, WCST, TMTs, and NBT. No significant group difference was observed between the OD and OCaD groups.
Discussion and Conclusions: Opioid dependence is associated with impairments in decision making, executive function, working memory, and attention. Co-morbid cannabis dependence had similar profiles of cognitive impairments.
Scientific Significance: Co-morbid cannabis dependence might not add on to the existing cognitive dysfunction in opioid dependence. Further studies should be done with a larger sample. (Am J Addict 2020;29:120-128).
(© 2020 American Academy of Addiction Psychiatry.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies